Healthcare Stocks. Value Trap or Opportunity? Part 1 of 2

Here's a comprehensive summary of the YouTube video transcript:

Key Concepts

• Healthcare Sector Valuation: Healthcare stocks are currently at a 24-year low relative to the S&P 500, with a 30-year low in price-to-earnings (P/E) ratios.
• Investor Sentiment: Significant outflows from the healthcare sector indicate institutional and retail investors are selling.
• Broken Stock vs. Broken Business: A crucial distinction for investment decisions. A "broken stock" has a temporarily depressed price due to external factors, while a "broken business" has fundamental issues leading to declining sales and profits.
• Economic Moat: A company's sustainable competitive advantage, crucial for long-term success.
• Medical Loss Ratio (MLR): The percentage of premium revenue an insurer spends on medical claims and healthcare services.
• UnitedHealth Group (UNH): A major player in managed healthcare, facing scrutiny over alleged Medicare fraud and rising medical costs.
• Novo Nordisk (NVO): Mentioned as a pharmaceutical stock with a small stake held by the speaker.

Healthcare Sector Valuation and Investor Sentiment

The video begins by highlighting that healthcare stocks are currently cheaper than they were two months prior, presenting a potential opportunity or a "value trap." Data from TradingView, comparing the healthcare ETF (XLV) to the S&P 500 ETF (SPY), shows healthcare stocks at a 24-year low relative to the broader market, not seen since the year 2000. Furthermore, the price-to-earnings (P/E) ratio of the healthcare sector relative to the S&P 500 is at a 30-year low. This cheapness is corroborated by charts showing significant outflows from the healthcare sector, indicating that both institutional and retail investors are selling. The central question posed is whether this is a temporary cyclical sell-off in a secular growth industry or a sign of fundamental decline.

Sub-Sector Performance within Healthcare

Not all healthcare stocks are performing poorly. The speaker mentions owning HCA Healthcare (a hospital chain) and Idex Laboratories (animal diagnostics equipment), both of which have been performing well. The IHI medical devices ETF is also noted as doing well.

The broader healthcare sector, represented by XLV, is down 8.8% over the last year. However, the sector is broken down into three sub-sectors:

1. Medical Devices (ETF: IHI): Performing "pretty okay."
2. Pharmaceuticals (ETF: XPH): Performing "not terribly badly but not great either," described as "kind of like flat." The speaker generally avoids investing in pharmaceutical stocks but holds a small stake in Novo Nordisk.
3. Managed Healthcare (ETF: IHF): This sub-sector is identified as the primary driver of the overall healthcare sector's decline. Companies like UnitedHealth, Humana, and Elevance Health are pulling the sector down.

The "Broken Stock" vs. "Broken Business" Framework

A core argument presented is the distinction between a "broken stock" and a "broken business."

• Broken Business: A company whose stock price has fallen significantly because the underlying business is fundamentally flawed. This includes a loss of competitive advantage, disruption, declining sales, falling profits, and actual money loss. These are stocks to avoid, sell, or cut losses on.
• Broken Stock (Not a Broken Business): A company whose stock price has dropped significantly (e.g., 50-60%) due to temporary, often emotional or narrative-driven factors, while the business itself remains strong, with growing sales and profits. These present great buying opportunities as the stock price is likely to rebound significantly once the narrative shifts.

Examples of Broken Stocks, Not Broken Businesses:

• Meta Platforms (META): In 2022, Meta's stock dropped 77% from its peak. Despite this, its financials showed continued revenue growth (with a slight dip) and net income, indicating a strong business. Its economic moat was assessed as very strong (8/10) due to billions of users on its platforms (Facebook, Instagram, WhatsApp). The stock has since rebounded by 74.46% from its bottom.
• Netflix (NFLX): In 2022, Netflix's stock also dropped 77%. While its profit took a slight dip, revenue continued to grow, and it was not losing money. Its economic moat was rated as narrow (6/10) due to brand loyalty and pricing power. The stock rebounded by 700% from its bottom.

Example of a Broken Stock and Broken Business:

• Intel (INTC): Intel's stock has fallen 74%. The speaker identifies it as a broken business due to a lack of economic moat, declining revenue, and consistent losses. The speaker would not buy Intel because its business is not making money.

Analysis of UnitedHealth Group (UNH)

The speaker applies the "broken stock vs. broken business" framework to UnitedHealth Group.

Is UnitedHealth a Broken Business?

The speaker emphasizes the need for investors to remain rational and unbiased, looking purely at the numbers.

• Financials:
  • Revenue: Continues to grow, with the last quarter reporting 16% year-over-year growth, exceeding expectations.
  • Profitability: While profit growth has slowed in recent quarters, the company is still making money. Net income has been growing, with a slight drop in recent quarters but a jump back up in the last 12 months. Net operating cash flow is also increasing.
  • Economic Moat: Rated as "wide" (8/10) by AI. This is attributed to its dominant market leadership in managed care, massive economies of scale (50 million insured lives), and its Optum Health services (specialty clinics, surgical centers). High switching costs and barriers to entry contribute to its strong moat.
  • Financial Strength: Rated as "very strong."
  • Valuation: Rated as "high," indicating it is currently undervalued.

Based on these fundamentals, the speaker concludes that UnitedHealth is not a broken business.

Why Has the Stock Price Dropped Over 60%?

Two main concerns are identified:

1. DOJ Investigation for Alleged Medicare Fraud: The company is accused of overbilling Medicare Advantage plans by claiming patients are sicker than they are.

   • Speaker's Perspective: The speaker is "not really concerned" because it's an accusation without systemic evidence, and historically, companies accused of worse fraud (e.g., Wells Fargo, Meta) have recovered and seen their stock prices rise significantly after paying fines. Wells Fargo's stock is up 121% since its scandals, and Meta is up 458% since its scandals. The speaker believes this will likely result in a small fine for UnitedHealth, allowing the company to move forward.

2. Rising Medical Costs and Lower Profitability: This is identified as the "main issue" affecting the entire industry, not just UnitedHealth.

   • The Problem: While sales revenue grew 16% to $11.62 billion in the last earnings report, earnings per share (EPS) came in at $4, lower than the anticipated $4.45. More significantly, the 2025 guidance projected EPS of $16, well below the market's expectation of $20 and a 30% drop from the 2023 EPS of $23.
   • Reason: An increase in the Medical Loss Ratio (MLR) from 80% to 89%. The MLR represents the percentage of premium revenue spent on medical claims.
   • Explanation of MLR: UnitedHealth collects premiums (e.g., $100). Historically, they spent about 80% ($80) on medical claims, leaving a $20 profit. However, due to inflation increasing medical costs and a backlog of delayed surgeries post-COVID, medical claims have risen to $89. UnitedHealth did not raise premiums sufficiently to cover this increase, leading to a profit of only $11 ($100 - $89).
   • Is it Short-Term or Long-Term? The speaker believes this is a short-term problem. Health insurance companies like UnitedHealth and Elevance Health can and will raise premiums in the coming quarters to restore their profit margins. They are already planning premium increases.

Future Outlook for UnitedHealth

• Premium Adjustments: The company is expected to increase premiums to around $110, which would bring the MLR back down to historical levels and allow profits to rebound.
• Profit Projections:
  • Current year: Expected 30% drop in earnings.
  • Next year: Expected profit growth of 7-9% as premiums are adjusted.
  • 2027: Expected profit growth of 11-13%.
  • 2028: Expected profit growth of 13-16%.
• Historical Growth: Historically, UnitedHealth's earnings have grown at 10.47%. Management believes they will return to this long-term growth rate after adjusting premiums.
• Premium Increases: A Wall Street Journal report indicates that insurers like UnitedHealth are seeking hefty premium rate increases for the Affordable Care Act marketplace in 2026 due to higher healthcare costs and changing federal policy.

Conclusion and Next Steps

The speaker concludes that UnitedHealth is a "broken stock" but not a "broken business." The current stock price drop is primarily due to a temporary increase in medical costs and a failure to adjust premiums accordingly, coupled with a DOJ investigation that the speaker views as a minor concern. The ability to raise premiums suggests a rebound is likely.

The video ends by stating that the intrinsic value of the stock and whether the share price can go lower will be covered in "Part Two" of the video. The speaker encourages viewers to subscribe and check out their online courses and live Wealth Academy program.